Willow Biosciences Management
Management criteria checks 3/4
Willow Biosciences' CEO is Chris Savile, appointed in Mar 2023, has a tenure of 1.08 years. total yearly compensation is CA$584.32K, comprised of 61.2% salary and 38.8% bonuses, including company stock and options. directly owns 0.72% of the company’s shares, worth $60.46K. The average tenure of the management team and the board of directors is 4.9 years and 1.2 years respectively.
Key information
Chris Savile
Chief executive officer
CA$584.3k
Total compensation
| CEO salary percentage | 61.2% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.7% |
| Management average tenure | 4.9yrs |
| Board average tenure | 1.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CA$13m |
| Sep 30 2023 | n/a | n/a | -CA$15m |
| Jun 30 2023 | n/a | n/a | -CA$17m |
| Mar 31 2023 | n/a | n/a | -CA$17m |
| Dec 31 2022 | CA$584k | CA$358k | -CA$15m |
| Sep 30 2022 | n/a | n/a | -CA$15m |
| Jun 30 2022 | n/a | n/a | -CA$7m |
| Mar 31 2022 | n/a | n/a | CA$2m |
| Dec 31 2021 | CA$743k | CA$297k | -CA$6m |
| Sep 30 2021 | n/a | n/a | -CA$16m |
| Jun 30 2021 | n/a | n/a | -CA$27m |
| Mar 31 2021 | n/a | n/a | -CA$44m |
| Dec 31 2020 | CA$447k | CA$297k | -CA$34m |
| Sep 30 2020 | n/a | n/a | -CA$22m |
| Jun 30 2020 | n/a | n/a | -CA$16m |
| Mar 31 2020 | n/a | n/a | -CA$45m |
| Dec 31 2019 | CA$789k | CA$209k | -CA$45m |
Compensation vs Market: Chris's total compensation ($USD427.68K) is below average for companies of similar size in the US market ($USD670.12K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Savile
1.1yrs
Tenure
CA$584,324
Compensation
Dr. Chris Savile serves as President and Chief Executive Officer Willow Biosciences Inc. since March 28, 2023. He served as its Chief Operations Officer since April 7, 2020 until 2023. Dr. Savile served as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.1yrs | CA$584.32k | 0.72% CA$ 60.5k | |
| Chief Financial Officer | 5yrs | CA$470.40k | 0.86% CA$ 72.1k | |
| Senior Vice President of Research & Development | 1.1yrs | CA$424.89k | 0.34% CA$ 28.7k | |
| Vice President of Corporate Development | 4.9yrs | CA$220.12k | no data | |
| Corporate Secretary | 5yrs | no data | no data |
4.9yrs
Average Tenure
Experienced Management: CANS.F's management team is considered experienced (4.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.1yrs | CA$584.32k | 0.72% CA$ 60.5k | |
| Independent Director | 5yrs | CA$81.84k | 1.19% CA$ 99.6k | |
| Independent Chairman | 1.2yrs | no data | 0.024% CA$ 2.0k | |
| Director | 5yrs | CA$81.84k | 0.056% CA$ 4.7k | |
| Independent Director | less than a year | no data | no data |
1.2yrs
Average Tenure
58yo
Average Age
Experienced Board: CANS.F's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.